Dyne Therapeutics 40% Rally Faces Fund Selloff Questions
A dramatic 40% jump for Dyne Therapeutics has investors watching closely as a biotech-focused fund disclosed a sizabl...
Quick take on safety: bonds vs cash in retirement, highlighting scenarios where each preserves capital and meets withdrawal needs.
24,731 articlesA dramatic 40% jump for Dyne Therapeutics has investors watching closely as a biotech-focused fund disclosed a sizabl...
A potential hawkish shift in monetary policy could derail the AI stock surge, threatening lofty earnings multiples fo...
Two aviation ETFs pull in opposite directions: JETS targets airlines and airports, ITA leans into defense and aerospa...
Axon Enterprise stock popped as investors weighed the company’s expanding product lineup, software growth, and a grow...
Tesla delivers a long-awaited autonomy milestone with unsupervised robotaxi rides in Dallas and Houston, sending TSLA...
Dell Technologies leads the pack in 2026 among AI server stocks, outpacing Hewlett Packard Enterprise and Super Micro...
As AI infrastructure spending stays robust, memory names SanDisk and Micron pursue starkly different paths. SanDisk l...
A high-profile hedge fund reveals a fresh stake in Clearwater Analytics, the investment accounting platform. We break...
A major adviser boosted its stake in Savara by more than a million shares during the latest quarter, wading into a bi...
Johnson & Johnson and AbbVie report strong Q1 2026 results, showcasing two contrasting growth paths as biosimilar cha...
Two popular consumer sector ETFs sit at the crossroads of liquidity and diversification. XLY concentrates on large‑ca...
If you’re weighing fncl kbwb: broad financial exposure against a concentrated bank bet, this guide breaks down how ea...